One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today.
This is an archival story that predates current editorial management.
This archival content was written, edited, and published prior to LAist's acquisition by its current owner, Southern California Public Radio ("SCPR"). Content, such as language choice and subject matter, in archival articles therefore may not align with SCPR's current editorial standards. To learn more about those standards and why we make this distinction, please click here.
ICYMI: Chairman Of Mylan (Makers Of The EpiPen) Was Paid $100 Million In 2016
(Photo by Jordan Barab via the LAist Featured Photos pool on Flickr)
- Follow LAist on Twitter, on Instagram, and like us on Facebook. And to get the top stories mailed to you, sign up here.
- The pharmaceutical company Mylan (who faced controversy last year for hiking the price of the Epipen) is facing backlash from its own investors for what some regard as exorbitant payrolls. For instance, one chairman made about $100 million last year.
- An appreciation of NBC's Night Court. John Larroquette, anyone?
- Before he became inextricably tied to Watergate, Carl Bernstein was doing some trailblazing work in critiquing pop culture.
- Elon Musk says he will quit Trump's business advisory council if the President decides to withdraw from the Paris climate agreement.
- Speaking of the President and climate change, Trump's at odds with the Pentagon about the dangers of global warming.
- Could the new Wonder Woman movie bring glory back to DC Comics? The reviews are looking pretty strong.
- Here's an afterschool special to set you straight. This is also some of Scott Baio's finest work.